Boehringar-ingelheim.com

The timeline behind boehringar-ingelheim.com

Registration, the decision and the archived record of what this domain actually displayed — from public RDAP and the Internet Archive.

Result of record. The panel's reasoning and decisive facts behind each element are in the Intelligence dossier below.

Case number CAC-UDRP-104403 Time of filing 2022-03-09 09:50:49 Domain names boehringar-ingelheim.com Case administrator Organization Denisa Bilík (CAC) (Case admin) Complainant Organization Boehringer Ingelheim Pharma GmbH & Co.KG Complainant representative Organization NAMESHIELD S.A.S. Respondent Name Regina Keisa Other Legal Proceedings The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name. Identification Of Rights The Complainant has rights in the registered international trademarks BOEHRINGER-INGELHEIM n°221544, registered on July 2, 1959 and n°568844 registered on March 22, 1991. Factual Background FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT: Founded in 1885, the Complainant is a global research-driven pharmaceutical enterprise with roughly 52,000 employees. In 2020, the Complainant achieved net sales of 19.6 billion Euros. The Complainant owns a large portfolio of trademarks including BOEHRINGER INGELHEIM in several countries and multiple domain names incorporating that mark, such as <boehringer-ingelheim.com> registered since September 9, 1995. The disputed domain name <boehringar-ingelheim.com> was registered on March 3, 2022. It resolves to an inactive page. MX servers are configured. The Respondent has no rights or legitimate interests in respect of the domain name <boehringar-ingelheim.com> and is not related in any way to the Complainant. The Complainant does not carry out any activity for, nor has any business with the Respondent. Neither licence nor authorization has been granted by the Complainant to the Respondent to make any use of the Complainant’s trademark BOEHRINGER-INGELHEIM, nor to apply for registration of the disputed domain name. Given the distinctiveness of the Complainant's trademark and its reputation, it is reasonable to infer that the Respondent has registered and uses the disputed domain name with full knowledge of the Complainant's trademark. The disputed domain name is a typosquatted version of the BOEHRINGER-INGELHEIM trademark. It resolves to an inactive page. Therefore, the Respondent has not made any use of the disputed domain name since its registration. This confirms that the Respondent has no demonstrable plan to use the disputed domain name. The registration of the domain name <boehringar-ingelheim.com> with the misspelling of the trademark BOEHRINGER-INGELHEIM, was intentionally designed to be confusingly similar to the Complainant’s trademark. Previous UDRP Panels have seen such actions as evidence of bad faith. See for instance WIPO Case No. D2016-1546, Boehringer Ingelheim Pharma GmbH & Co. KG v. Martin Hughes <boehringer-ingalheim.com> (“the registration of the Domain Name which contains obvious misspelling of the Complainant’s BOEHRINGER INGELHEIM trademark and which is virtually identical to the Complainant’s <boehringer-ingelheim.com> domain name constitutes registration and use bad faith.”) Parties Contentions NO ADMINISTRATIVELY COMPLIANT RESPONSE HAS BEEN FILED. Rights The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy). No Rights or Legitimate Interests The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy). Bad Faith The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy). Procedural Factors The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision. Principal Reasons for the Decision In light of the Complainant's submissions and the absence of any response, the Panel finds that the Complainant has shown that it has rights in the BOEHRINGER-INGELHEIM trademark, which is famous, and has established that the Respondent has no rights or legitimate interests in the disputed domain name, which was registered in bad faith by the Respondent with full knowledge of the Complainant's famous mark. Further, as in the leading case of Telstra Corporation Limited v. Nuclear Marshmallows, WIPO Case No. D2000-0003, there is no conceivable active use that could be made of the typosquatted domain name that would not amount to an infringement of the Complainant’s trademark rights. Accordingly, the Panel finds that the Respondent's passive use of the disputed domain name constitutes use in bad faith. For all the reasons stated above, the Complaint is Accepted and the disputed domain name(s) is (are) to be BOEHRINGAR-INGELHEIM.COM: Transferred PANELLISTS Name Mr. Alan Lawrence Limbury Date of Panel Decision 2022-04-02 Publish the Decision

Source of record: CAC . Reproduced for research; CAC is the authoritative source.